Patient's exact age is unknown; however, it was reported that the patient was over the age of 18.Date of event was approximated to (b)(6) 2018 as no specific event date was reported.(b)(4).The complainant indicated that the suspect device remains implanted and will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental mdr will be filed.
|
It was reported to boston scientific corporation on november 28, 2018 that an ultraflex esophageal covered distal release stent was implanted to treat a postoperative anastomotic fistula in the esophagus (following total gastrectomy due to cancer) during a gastroscopy with stent placement procedure performed on an unknown date.According to the complainant, post stent placement procedure, a leak of contrast medium in the esophagus was observed on the fluoroscopic images.Reportedly, the physician presumed that there was a breach in the silicone covering of the stent due to spillage.The stent remained implanted, and the patient was under observation.Reportedly, per the physician, there was a failure in the reabsorption of the fistula.Two radiological drainages were positioned to facilitate reabsorption, and a nasogastric tube was attached to the patient.On (b)(6) 2018, boston scientific corporation received a follow-up information that the patient was in a delicate condition and has expired.The patient's death was due to the non-reabsorption of the anastomotic fistula.The correlation between the patient's death and the stent could not be confirmed, as there was a spreading of the contrast medium seen on the x-ray images.Note: according to the complainant, the stent was implanted to treat a postoperative anastomotic fistula in the esophagus (following total gastrectomy).According to the dfu, the ultraflex esophageal ng stent system is contraindicated for "placement in an esophago-jejunostomy (following gastrectomy), as peristalsis may displace stent.".
|